Surgeons at Pride Veterinary Centre have claimed a UK-first for a procedure in which they used a tailor-made titanium implant to replace a cancerous vertebra in a nine-year-old Staffordshire Bull Terrier.

The dog presented to the Neurology and Neurosurgery Service at Pride after the dog's GP vet had diagnosed a tumour.

The neurological examination was consistent with a thoracolumbar lesion and the X-rays showed a radiopaque mass with bony lysis on the third lumbar vertebral body.

Annette Wessmann, an EBVS European Specialist in Veterinary Neurology at Pride said: “We chose to do a CT scan based on examination and the X-rays.

“It confirmed the suspicion of a neoplastic lesion and ruled out other tumoral focus along the rest of the spine and other organs."

A customised titanium implant was designed for the dog's spine in collaboration with BETA Implants.

Rosario Vallefuoco, an RCVS and EBVS Small Animal Surgery Specialist and Head of Small Animal Surgery at Pride said: “It was a case of combining our experience with that of the engineers.

“The original implants had been designed for humans, and we had to imagine what would be required for a dog and work out at every step what changes we would have to make.”

The surgery took place in three different stages, the first being L3 vertebra skeletonization and dorsal lamina removal.

The second step was vertebral body removal.

Finally, the third step was vertebral reconstruction using the designed implants.

The whole procedure took six hours, and the dog was up and walking again within 12 hours.

Subsequent histopathology assessment of the mass confirmed osteosarcoma, so the surgery is being followed up with chemotherapy.

Following the success of the surgery, Pride Veterinary Referrals says it now hopes to help other dogs with similar conditions.

www.prideveterinaryreferrals.com

Defra has announced plans to form a new Animal Health and Welfare Board for England which will bring experts including farmers, veterinary surgeons, welfare experts and others from outside Government together with the Chief Veterinary Officer and civil servants to make direct policy recommendations on policy affecting the health and welfare of all kept animals such as farm animals, horses and pets.

According to Agriculture Minister Jim Paice, it is the first time that people affected by Government policy on animal health and welfare will make recommendations on those policies directly to Ministers.

Mr Paice said: "This is a completely new way of working.  It replaces the old ways, where the people most affected by decisions were kept at arm's length from policy making on those subjects.

"This is about the Big Society not just existing in our communities, but in the heart of Government - helping to put the decisions in the hands of those who are doing the work on the ground.

"We've already seen the success of a partnership between farmers and the Government with the work that's been done on bluetongue - which has seen the disease virtually eradicated in this country."

Final decisions on animal health and welfare policy will remain in the hands of Government Ministers. 

The Board will be made up of around 12 members, 5 senior Defra officials including the Chief Veterinary Officer, and 7-8 external members including the chair. The external members will have experience and knowledge of kept and farmed animals, animal and veterinary science, and animal welfare, and could be farmers, veterinarians, animal welfare experts. 

The Board and its members will have to represent the views of all stakeholders so will be expected to communicate with them regularly.

The Board's responsibilities will include:

• setting the strategic policy priorities;
• development of key policies and how they should be funded;
• assessing the risk of threats from animal disease and how to manage them;
• determining the surveillance and research priorities;
• reviewing and developing contingency plans for dealing with new disease outbreaks; and
• considering, what if any, charging mechanisms should be introduced.

The Board will not be set up as a non departmental public body or arms length body.  It will form part of the internal structure of Defra.

Commenting on the announcement, Harvey Locke, President of the British Veterinary Association, said: "The BVA is delighted that both the Advisory Group and Ministers have taken note of the veterinary profession's views in drawing up these plans.

"We said from the outset that genuine responsibility sharing has to be achieved before cost sharing can be discussed and we warned against earlier plans to separate animal health policy from animal welfare policy, as the two are intrinsically linked.

"Animal health and welfare policy issues require expert, scientific input and it will be essential that the new Board includes veterinary representation. We believe that the Board will provide the right mechanism for ensuring decisions are based on sound science.

"The new Board will also have to work closely with the three devolved administrations to ensure that animal health and welfare policies across the UK are joined up and complementary."

Feline charity International Cat Care (iCatCare)'s annual cat photography competition is now open for entries.

This year, in collaboration with Your Cat, the charity is looking for entries which showcase the cat-human bond with a brand new theme of ‘Cat-Human Relationships’.

The judges want to see a range of relationships in a variety of situations, locations and ages. For instance, entries can include but are not limited to: pet cats with their owners in the home, street cats with the public and cats with those who work with them eg, veterinary professionals with their patients and homing centre workers with the cats in their care.

Since its launch in 2013, the competition has collectively attracted over 15,000 entries from all over the world.

Eve Davies, who runs the competition, said: "Whilst we tend to think of our relationship with cats as that of pet and owner, cats and humans can have a huge variety of unique connections with each other and we would love to see this reflected in the entries.

"This year’s theme is quite different to previous topics – for example kittens or sleeping cats – but it has the potential to be much more rewarding. As well as receiving exceptional photos over the years, we have been sent some incredibly moving stories to accompany them and we are hoping that this year will be even better still."

Twelve winning images will be selected by the iCatCare and Your Cat Magazine judges to feature in the charity’s 2020 calendar (and other materials) which will be sold to raise funds for the charity’s work, with one crowned the overall winner and gracing the front cover.

All twelve winners will each receive a certificate, copies of the calendar and a selection of iCatCare merchandise. The overall winner will also receive £500 in prize money.

To find out more and to enter, visit: www.icatcare.org/photography-competition. The competition closes at 10 am (BST) on 1 July 2019. 

A survey of veterinary professionals conducted by the Veterinary Management Group and the Society of Practising Veterinary Surgeons has concluded that veterinary leaders, chiefly vets and practice managers, lack the man management skills needed to improve staff motivation and retention. 

330 people who took part in the survey were presented with a list of management and leadership skills. Those of the respondents who are leaders were asked to rate their confidence in applying the skills, whilst those in non-management positions were asked to rate their line manager's skills. Both sets of respondents were also asked to place the skills in priority order.

The management skills were: Setting clear tasks and objectives. Providing clear roles and responsibilities. Communicating clearly and effectively. Monitoring and evaluating. Planning and organising. Effectively managing difficult situations.

The leadership skills were: Providing rationale and explaining why. Regularly providing and seeking feedback. Building trust. Providing guidance and training. Creating development plans and opportunities.

Interestingly, the survey found a close correlation between how the leaders and the employees prioritise these things, with management skills being perceived as more important overall than leadership skills. 

Communicating clearly and effectively was deemed the most important skill of all (ranked 9 out of 10 by both groups). Meanwhile, creating development plans and opportunities for others was prioritised the least (ranked 3.7/10).

But hang on a moment. If both the managers and the employees agree that creating development plans and opportunities is the least important thing, then surely it is? In other words, if employees say that creating development plans is unimportant, then surely it is unimportant, and if leaders think the same, they would appear to be right.

Maybe, maybe not. Perhaps employees don't know what's good for them, and leaders don't know what employees don't know what is good for them. If you take my point. 

Veterinary leaders were then asked to rate their confidence in applying the listed leadership and management skills. The skills which elicited the largest number of 'not confident' responses were: monitoring and evaluating performance, regularly providing and seeking feedback, and creating development plans and opportunities for others.

The skills with which leaders were most confident were: communicating clearly and effectively, building trust, and providing rationale and explaining why. 

Again, there was a close correlation between prioritisation of these skills and confidence levels. 

VMG Vice President Richard Casey said: “The survey has helped us to identify priorities for learning and development both at our 2020 Congress and during our joint CPD programme next year.  It is striking that the very skills required to motivate colleagues to remain in veterinary medicine and to support them in doing so are the ones which so many veterinary leaders admit that they lack confidence. Given the challenges the profession faces, it is also concerning that they appear to be undervalued both by veterinary leaders and the team members who report to them.

"Delegates to SPVS-VMG Congress and our other 2020 CPD events will benefit from a wealth of evidence-based lectures from experts on all aspects of veterinary leadership and management, enabling them to improve their own performance and contribute to an overall raising of standards of leadership and management across the veterinary sector." 

Peter Brown, Senior Vice-President of SPVS, said: "We know that veterinary students receive an excellent clinical training and, in recent years, universities have started to include more non-clinical skills on the curriculum. However, these results suggest that when professionals move into more senior roles, be it leading a team or running their own practice, they find they still need to acquire new skills. SPVS’ role has always been to equip veterinary professionals to be effective leaders and SPVS-VMG congress is an excellent opportunity to both hear inspiring speakers and meet and learn from fellow leaders within the profession."

The VMG-SPVS 2020 joint Congress takes place from 23-25 January at the Celtic Manor Resort, Newport, and will feature dedicated streams on effective leadership, management mastery, practice profitability, preparing for a digital future and sustainability in practice.

Details on the VMG-SPVS 2020 CPD Programme can be found here: https://spvs-vmg-events.co.uk/cpd-events/ 

A new study, published in the latest issue of the Journal of Small Animal Practice (JSAP), has found that the addition of antacid treatment during the pre- and postoperative period for brachycephalic dogs undergoing surgery may result in a faster and greater improvement in treated dogs.

The study titled “Diagnosis and treatment of gastro-oesophageal junction abnormalities in dogs with brachycephalic syndrome” included thirty-six client-owned brachycephalic dogs (French bulldogs, pug and English bulldogs) in a prospective, randomised trial.

Antacid treatment (omeprazole (1mg/kg PO q24 hours) and magaldrate (5-10mL/dog PO q8-12 hours)) was randomly prescribed in 18 dogs before and after surgery, while the other 18 dogs did not receive any gastrointestinal medical treatment.

Digestive clinical signs and gastro-oesophageal junction abnormalities (GJA) were assessed and scored at presentation, at the time of surgery and at recheck. GJA were assessed during endoscopy in standard conditions, as well as during endotracheal tube obstruction. All endoscopic procedures were recorded and reviewed by a single, blinded reviewer.

In order to assess whether endotracheal tube obstruction manoeuvre accurately detects GJA, the procedure was also performed during the examination of the gastro-oesophageal junction in a group of 10 control dogs. Control dogs were healthy or had diseases that were not expected to interfere with gastro-oesophageal junction dynamics, and were anaesthetised for independent purposes.

Dr Emilie Vangrinsven, corresponding author for the paper said: "Although results of multivariate analysis failed to demonstrate a direct effect of antacid treatment, a significant interaction between antacid treatment status and improvement of digestive clinical score throughout the endoscopies was present, meaning that treated animals seem to improve faster and have lower clinical scores after surgery than untreated animals. Furthermore, a significant improvement in GJA-obstruction score was present in the treatment group only.

"In contrast to standard endoscopy, the obstruction manoeuvre during endoscopy allowed detection of GJA in dogs, even in the absence of clinical signs. We were concerned that the obstruction manoeuvre may induce false positive results for the diagnosis of dynamic GJA; in the control group, GJA during obstruction manoeuvre were found to be negligible suggesting that this technique does not significantly overestimate the presence of GJA.”

Nicola Di Girolamo, Editor of JSAP said: "Based on this study, antacid treatment administered to brachycephalic dogs undergoing surgery may be beneficial. It should be noted that a direct influence of antacid treatment on digestive clinical and lesion scores could not be significantly demonstrated, which may have been because of the lack of an actual difference, or as a result of the small sample size.”

The full article can be found in the March issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13279  

Reference

1. E. Vangrinsven, O. Broux, L. Massart, S. Claeys, C. Clercx and F. Billen (2021) Diagnosis and treatment of gastro-oesophageal junction abnormalities in dogs with brachycephalic syndrome. Journal of Small Animal Practice, 62 (3). Available at: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13279  

Photo: Professor Ian Ramsey

The BVA and RCVS have announced the formation of the Vet Futures Action Group to take forward the ambitions and recommendations in the Vet Futures report ‘Taking charge of our future: A vision for the veterinary profession for 2030’ launched in November 2015.

The call for applications attracted more than 80 candidates with many more expressing an interest in helping to take the project forward. 

The Action Group will be tasked with working collectively to turn the report’s 34 recommendations into clear actions with buy-in from across the veterinary profession and a timetable for activity. 

The Action Group is made up of the BVA and RCVS Presidents and Junior Vice-Presidents, seven veterinary surgeons, a veterinary nurse, and a co-opted veterinary student: 

• Dr Clare Allen MA VetMB PhD MRCVS – Senior Teaching Assistant for curriculum and innovation in the Department of Veterinary Medicine at the University of Cambridge.
• Simon Doherty BVMS MRCVS CBiol FRSB – Owner and Director of Blackwater Consultancy and animal science expert for the Agri-Tech Organisation of UK Trade & Investment (UKTI).
• Daniel Hogan RVN – Operations Manager at Dick White Referrals.
• Dr Liz Mossop BVM&S PhD MRCVS – Assistant Professor of Veterinary Education and Sub-Dean for Teaching, Learning and Assessment at the School of Veterinary Medicine and Science, University of Nottingham.
• Gudrun Ravetz BVSc MRCVS  - BVA Junior Vice-President and Veterinary Consultant to Pet Health Plans from Denplan.
• Dr Kimberley Schiller BVetMed MRCVS – Manager in Healthcare Practice at Accenture, the global consultancy. 
• Dr Huw Stacey BVetMed DipAS(CABC) MRCVS – Director of Clinical Services at the Pets at Home Vet Group (PAHVG).
• Dr Mary Thomson BVMS MRCVS – small animal veterinary surgeon at New Street Vets in Devon, Vetlife Board member and RCVS Postgraduate Dean.
• Dr Chris Tufnell BSc (Hons) BVMS MRCVS  - RCVS Vice-President and Director of Coach House Vets, a small animal and equine practice in Berkshire.
• Dr Bradley Viner BVetMed MSc(VetGP) DProf MRCVS – RCVS President and Principal of Blythwood Vets, a group of small animal practices in North West London.
• Sean Wensley BVSc MSc Grad DMS MRCVS – BVA President and Senior Veterinary Surgeon for Communication and Education at the People’s Dispensary for Sick Animals (PDSA).
• Dr James Yeates BVSc BSc DWEL DipECVS(AWBM) PhD MRCVS – RSPCA Chief Veterinary Officer and honorary lecturer at the University of Bristol and University of Surrey.

The members of the Group joining the BVA and RCVS officers were selected by the Vet Futures Project Board for their mix of experience and expertise across the Vet Futures ambitions and themes (Animal health and welfare; Veterinary professionals’ wider roles in society; The health and wellbeing of veterinary professionals; Diverse and rewarding veterinary careers; Sustainable businesses and user-focused services; and Leadership), as well as in veterinary education, veterinary regulation, and veterinary nursing.

BVA President Sean Wensley said: "The Group has a very important task ahead and we are confident that we have an excellent group of people with the right balance of skills, experience and expertise to take forward the Vet Futures recommendations and turn them into concrete actions. 

"We have had an incredibly positive response from the profession to the launch of the report and we hope organisations and individuals will now step up to work with the Action Group and take ownership of the activity for the good of the whole profession."

RCVS President Bradley Viner said: "We were overwhelmed by the response from the professions with ten applications for every place, and many more offers of support. The Project Board was particularly impressed by the high quality of the applications and the breadth of experience demonstrated by the candidates from all parts of the profession. 

"It was incredibly difficult to select the members of the Group from such a strong field but we are pleased that we have captured the variety within the profession as well as the enthusiasm to drive the project forward. We sincerely hope everyone who expressed an interest will remain engaged with the project as it progresses this year."

A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.

The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.

Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.

Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.

Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).

The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.

The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.

The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.

Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.

According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.

Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."

The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.

Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."

Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.

The BVA has called on the RCVS to end temporary guidance that allows veterinary surgeons to prescribe POM-V products remotely without first having physically examined the animal.

In mid-September, the Association wrote to the RCVS expressing concern about the August extension to the temporary guidance.

In the latest update from the RCVS, the temporary measure has now been extended to 31 October but the flowchart and guidance have been updated to add some additional steps before a POM-V product can be prescribed remotely.

The BVA says that while it supported the original decision in March as a pragmatic solution and direct response to government restrictions surrounding Covid-19, it is now questioning the ongoing need for such a relaxation in the rules.

In the letter to the RCVS, the BVA also asked for a timeframe for the publication of the results of the RCVS survey of practices’ experiences of remote consulting and prescribing. The Association's own under care working group, chaired by Nigel Gibbens, has been developing a position to respond to the RCVS review. 

BVA President James Russell (pictured right) said: "We understand that allowing remote prescription of POM-Vs was a necessary measure at the height of the lockdown, as practices struggled to assess patients in person.

"However, the veterinary professions have done a fantastic job in adapting to the restrictions and are now able to work safely and see patients.

"Whilst we recognise the RCVS has provided additional guidance for the remote prescribing of POM-V, we cannot currently see any reason why a new client would be unable to access in-person veterinary care in the first instance and we are asking RCVS Council to reconsider this measure when it meets in Oct.

"It makes sense to continue allowing vets to remotely prescribe for existing patients, for example if an owner is shielding, but we feel it is no longer appropriate to be remotely prescribing to animals that have never been physically examined by the vet.

“The question of whether we should be able to remotely prescribe POM-V products without first seeing an animal is an important and live debate, and we welcome the resumption of the College’s review. But the longer that temporary measures are in place, the greater the expectation from animal owners that they will always be in place, and the harder it will be to have the discussion about the best way forward.

“As a profession, we are rightly concerned about antimicrobial resistance and we pride ourselves on the responsible use of medicines. Continually extending the temporary measures without a full analysis would risk undermining our position.”

The Veterinary Surgery in Lowestoft is launching a radioactive iodine therapy service for veterinary practices in the East of England to refer hyperthyroid cats from 5th June.

The service will be run by Dr Eloise Quince BVetMed CertAVP(SAM-F) PgCertVPS MANZCVS MRCVS and Dr Kate Allgood BVetMed CertAVP(SAM) MRCVS.

The practice says radioactive iodine therapy is the treatment of choice for hyperthyroid cats as it provides a permanent cure in up to 95% of cases.

It is administered by an iodine injection under the skin in a specialised unit by a trained vet and nurse. 

The practice says a benefit of RI is that it treats ‘ectopic tissue’ that may be present outside of the thyroid gland, for example in the chest, which is not treated by surgical methods of thyroid removal.

Normal thyroid tissue is also spared, so that there is normal thyroid function post-treatment.

Though some blood tests need to be taken post-treatment, there is no need for ongoing blood samples and the monitoring of the thyroid function once successful treatment has occurred.

Elissa Norman, Clinical Director, who initially developed the idea for the iodine unit said: “The iodine unit first started as a scribble on a piece of paper and a dream of our team back in 2017 and it has taken a huge amount of dedication and effort from a large team of people to get to the point of opening in 2023.

"Radioactive iodine offers a lifetime cure for our hyperthyroid cats and we are delighted to be able to bring this service to the cats of East Anglia.”

To refer a cat patient, vets should email iodine@veterinary-hospital.co.uk.

The British Small Animal Veterinary Association has announced the appointment of Dr Frances Barr as Academic Director, tasked with developing the new BSAVA postgraduate qualification in association with the Open University, ready for launch in 2012.

Frances is a European Specialist in Veterinary Diagnostic Imaging, and a double diplomat of the Royal College of Veterinary Surgeons and the European College of Veterinary Diagnostic Imaging. She has worked both in practice and as an academic, with 26 years working in Higher Education, and has a long history of working as a BSAVA volunteer, eventually taking on the presidential mantle in 2007.

BSAVA says it aims to provide the best possible educational offering to the profession, particularly to those in practice. Grant Petrie, BSAVA President, said: "Producing a postgraduate qualification is a natural progression to BSAVA's current CPD offering - there is clearly a need for it and we have a strong legacy as a provider of quality CPD. We want to make sure that the profession is served well - with a programme designed by vets for vets. As a charity with education at the core of our remit, BSAVA is best positioned to create something that will keep investing in the knowledge and talent of the profession. However, we always knew that we would need an exceptional individual to oversee the programme, and, in Frances Barr, we know we have that person."

Frances said: "This will fill a really important need. Many practitioners have a real appetite for learning more about their particular area of interest. Of course, they can currently do this with general CPD courses, but this new qualification will provide a structured and focussed learning programme which is flexible enough to fit around the busiest lifestyle, yet challenging enough to make the qualification a personal achievement, one that will be well respected by the whole profession."

She added: "The proposed new certificates in small animal medicine and surgery will comprise a combination of traditional taught courses, a wide-range of web-based material that will include interactive sessions, and workplace-based projects. This is the way forward for practitioners and will lead the profession into a more secure future."

The qualifications will be aimed primarily at the general practitioner, so they are not designed to replace the European Diploma system or aspiring to provide specialised knowledge. Instead they will be created very much for the interested, busy practitioner for whom an accredited residency programme is not an option. Grant Petrie said: "Encouraging small animal practitioners to embark on a clinically useful, challenging yet achievable, highly regarded postgraduate qualification sits very well with the BSAVA's remit to promote excellence in small animal practice through education and science."

The BSAVA postgraduate programme will launch in 2012, with more information about registration available at Congress 2011 and online from April next year. Frances Barr will begin working with the Open University and the BSAVA team in November.

Adam Mugford, BVetMed MVetMed DACVECC MRCVS, a RCVS Recognised Specialist in Emergency and Critical Care and Diplomate of the American College of Veterinary Emergency and Critical Care (ECC), has joined Lumbry Park Veterinary Specialists in Alton, Hampshire.

Adam, who is one of only 17 ECC Specialists in the UK, will be developing an ECC service at Lumbry Park.

Following graduation and an internship at the Royal Veterinary College, Adam worked in hospital and emergency general practice. He completed his residency in Emergency and Critical Care in 2013 becoming board certified the same year. He also completed a Master’s in Veterinary Medicine at the Royal Veterinary College.

Adam became an RCVS Recognised Specialist in Emergency and Critical Care in 2015. In his most recent role, he was Group Head of Emergency and Intensive Care for four RCVS-Recognised hospitals and branches and oversaw standards of out-of-hours provision to 50+ sites. He also led the development of the first specialist 24-hour veterinary intensive care unit in central London. 

Ray Girotti, Hospital Director, said: "Adam will be working with our multi-disciplinary team to offer a dedicated point of contact for emergency referrals, a move which will enhance the provision of critical care for our sickest patients. We are delighted to welcome a Specialist of his calibre to Lumbry Park."

Adam said: "The leadership on all issues relating to patient care shown by CVS’ Clinical Advisory Committee was inspiring and, with its full support, I have been offered an unrivalled opportunity to develop a leading ECC service at Lumbry Park. I’m really looking forward to my new role and to participating on the Clinical Advisory Committee to enhance ECC services right across CVS."

Bimeda has announced the launch of Bilovet, a new tylosin-based antibiotic for cattle and pigs.

Padraig Hyland, Head of Technical Veterinary Services at Bimeda said: ''It is with great pleasure that I announce the launch of our much anticipated Bilovet 200 mg/ml solution for injection for cattle and pigs as the latest addition to Bimeda's range of essential antibiotics.

Bilovet contains Tylosin 200 mg/ml and is the second Tylosin-based injectable antibiotic to be licensed for cattle - including dairy cattle - in the UK. Bilovet is licensed in cattle for the treatment of respiratory infections, metritis, mastitis, interdigital necrobacillosis and calf diphtheria as well as a range of pig infections, including enzootic pneumonia, haemorrhagic enteritis, erysipelas, arthritis and metritis".

Bimeda's Head of Bimeda R+D, Xavier Molins said: "Bilovet is a completely new development for a product that includes a new species (cattle). Bimeda have made a significant investment in bringing Bilovet to market, including conducting new Environmental Risk Assessment studies according to current guidelines and regulations.''

For more information, ring 01248 725 400 or email: uksales@bimeda.com